Annual Net Margin
-48.89%
-72.24%-309.38%
01 December 2023
Summary:
COSCIENS Biopharma annual net profit margin is currently -48.89%, with the most recent change of -72.24% (-309.38%) on 01 December 2023. During the last 3 years, it has fallen by -68.46% (-349.82%).CSCI Net Margin Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Net Margin
-307.59%
-246.74%-405.49%
01 September 2024
Summary:
COSCIENS Biopharma quarterly net profit margin is currently -307.59%, with the most recent change of -246.74% (-405.49%) on 01 September 2024. Over the past year, it has dropped by -185.33% (-151.59%).CSCI Quarterly Net Margin Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CSCI Net Margin Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | - | -151.6% |
| 3 y3 years | -349.8% | -944.3% |
| 5 y5 years | -456.2% | -8027.6% |
CSCI Net Margin High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | ||||
| 5 y | 5 years | ||||
| alltime | all time | -206.0% | -530.5% |
COSCIENS Biopharma Net Margin History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | -307.59%(+405.5%) |
| June 2024 | - | -60.85%(-10.7%) |
| Mar 2024 | - | -68.14%(-44.3%) |
| Dec 2023 | -48.89%(-309.4%) | -122.26%(+207.6%) |
| Sept 2023 | - | -39.75%(-35.7%) |
| June 2023 | - | -61.78%(+460.6%) |
| Mar 2023 | - | -11.02%(+94.0%) |
| Dec 2022 | 23.35%(+19.3%) | -5.68%(-121.6%) |
| Sept 2022 | - | 26.28%(-19.9%) |
| June 2022 | - | 32.82%(+11.7%) |
| Mar 2022 | - | 29.38%(-19.4%) |
| Dec 2021 | 19.57%(+59.5%) | 36.43%(+88.3%) |
| Sept 2021 | - | 19.35%(+26.1%) |
| June 2021 | - | 15.34%(+40.1%) |
| Mar 2021 | - | 10.95%(-184.8%) |
| Dec 2020 | 12.27%(-239.6%) | -12.91%(-334.3%) |
| Sept 2020 | - | 5.51%(-76.1%) |
| June 2020 | - | 23.08%(-12.4%) |
| Mar 2020 | - | 26.35%(+579.1%) |
| Dec 2019 | -8.79%(+223.2%) | 3.88%(-209.0%) |
| Sept 2019 | - | -3.56%(-80.5%) |
| June 2019 | - | -18.29%(-8.1%) |
| Mar 2019 | - | -19.91%(-267.5%) |
| Dec 2018 | -2.72%(-63.3%) | 11.89%(-184.6%) |
| Sept 2018 | - | -14.06%(+131.6%) |
| June 2018 | - | -6.07%(-53.3%) |
| Mar 2018 | - | -13.01%(-77.7%) |
| Dec 2017 | -7.41%(-128.0%) | -58.30%(-810.1%) |
| Sept 2017 | - | 8.21%(-29.6%) |
| June 2017 | - | 11.67%(+1983.9%) |
| Mar 2017 | - | 0.56%(-74.4%) |
| Dec 2016 | 26.47%(-42.6%) | 2.19%(-89.8%) |
| Sept 2016 | - | 21.38%(-45.5%) |
| June 2016 | - | 39.25%(+31.4%) |
| Mar 2016 | - | 29.86%(-8.7%) |
| Dec 2015 | 46.14%(+157.3%) | - |
| Sept 2015 | - | 32.69%(+21.3%) |
| June 2015 | - | 26.96%(-338.4%) |
| Mar 2015 | - | -11.31%(-654.4%) |
| Dec 2014 | 17.93%(+566.5%) | 2.04%(-92.8%) |
| Sept 2014 | - | 28.22%(+8.9%) |
| June 2014 | - | 25.91%(+185.4%) |
| Mar 2014 | - | 9.08%(-207.8%) |
| Dec 2013 | 2.69%(-125.8%) | -8.42%(-236.5%) |
| Sept 2013 | - | 6.17%(-124.8%) |
| June 2013 | - | -24.87%(-222.6%) |
| Mar 2013 | - | 20.28%(-200.3%) |
| Dec 2012 | -10.42%(-204.4%) | -20.22%(+90.0%) |
| Sept 2012 | - | -10.64%(-1.2%) |
| June 2012 | - | -10.77%(+3490.0%) |
| Mar 2012 | - | -0.30%(-101.9%) |
| Dec 2011 | 9.98%(+20.0%) | 15.87%(-322.9%) |
| Sept 2011 | - | -7.12%(-181.5%) |
| June 2011 | - | 8.74%(-59.4%) |
| Mar 2011 | - | 21.52%(+114.3%) |
| Dec 2010 | 8.32% | 10.04%(+74.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2010 | - | 5.75%(-75.5%) |
| June 2010 | - | 23.43%(-682.8%) |
| Mar 2010 | - | -4.02%(-96.9%) |
| Dec 2009 | -1.59%(-98.1%) | -130.99%(>+9900.0%) |
| Sept 2009 | - | -0.28%(-100.7%) |
| June 2009 | - | 38.44%(+462.0%) |
| Mar 2009 | - | 6.84%(-103.6%) |
| Dec 2008 | -85.13%(+111.2%) | -189.92%(+239.4%) |
| Sept 2008 | - | -55.96%(-25.1%) |
| June 2008 | - | -74.70%(+4.6%) |
| Mar 2008 | - | -71.44%(+5.5%) |
| Dec 2007 | -40.30%(+389.7%) | -67.73%(-33.5%) |
| Sept 2007 | - | -101.90%(+380.4%) |
| June 2007 | - | -21.21%(+838.5%) |
| Mar 2007 | - | -2.26%(-88.4%) |
| Dec 2006 | -8.23%(+288.2%) | -19.48%(+54.4%) |
| Sept 2006 | - | -12.62%(+3405.6%) |
| June 2006 | - | -0.36%(-93.7%) |
| Mar 2006 | - | -5.70%(-128.5%) |
| Dec 2005 | -2.12%(-89.6%) | 20.02%(-205.1%) |
| Sept 2005 | - | -19.05%(-293.6%) |
| June 2005 | - | 9.84%(-124.4%) |
| Mar 2005 | - | -40.27%(+63.5%) |
| Dec 2004 | -20.32%(-202.0%) | -24.63%(-76.2%) |
| Sept 2004 | - | -103.48%(+984.7%) |
| June 2004 | - | -9.54%(-147.5%) |
| Mar 2004 | - | 20.07%(-212.8%) |
| Dec 2003 | 19.93%(+156.2%) | -17.79%(-125.7%) |
| Sept 2003 | - | 69.18%(+146.0%) |
| June 2003 | - | 28.12%(+261.0%) |
| Mar 2003 | - | 7.79%(-65.0%) |
| Dec 2002 | 7.78%(-125.8%) | 22.27%(-22.1%) |
| Sept 2002 | - | 28.57%(+119.9%) |
| June 2002 | - | 12.99%(-119.7%) |
| Mar 2002 | - | -65.89%(-192.2%) |
| Dec 2001 | -30.11%(-73.4%) | 71.45%(-390.4%) |
| Sept 2001 | - | -24.60%(-76.3%) |
| June 2001 | - | -103.69%(+47.2%) |
| Mar 2001 | - | -70.46%(-95.5%) |
| Dec 2000 | -113.23%(-58.9%) | -1558.48%(+8976.8%) |
| Sept 2000 | - | -17.17%(-82.8%) |
| June 2000 | - | -100.00%(-50.0%) |
| Mar 2000 | - | -200.00%(-89.8%) |
| Dec 1999 | -275.76%(-92.3%) | -1965.05%(+5795.7%) |
| Sept 1999 | - | -33.33%(-66.7%) |
| June 1999 | - | -100.00%(0.0%) |
| Mar 1999 | - | -100.00%(-98.6%) |
| Dec 1998 | -3575.00%(+315.3%) | - |
| Sept 1998 | - | -7400.04%(>+9900.0%) |
| June 1998 | - | -25.00%(-93.8%) |
| Mar 1998 | - | -400.00%(-77.7%) |
| Dec 1997 | -860.87%(+39.6%) | -1792.87%(+527.5%) |
| Sept 1997 | - | -285.71%(-45.6%) |
| June 1997 | - | -525.00%(+31.3%) |
| Mar 1997 | - | -400.00% |
| Dec 1996 | -616.67% | - |
FAQ
- What is COSCIENS Biopharma annual net profit margin?
- What is the all time high annual net margin for COSCIENS Biopharma?
- What is COSCIENS Biopharma quarterly net profit margin?
- What is the all time high quarterly net margin for COSCIENS Biopharma?
- What is COSCIENS Biopharma quarterly net margin year-on-year change?
What is COSCIENS Biopharma annual net profit margin?
The current annual net margin of CSCI is -48.89%
What is the all time high annual net margin for COSCIENS Biopharma?
COSCIENS Biopharma all-time high annual net profit margin is 46.14%
What is COSCIENS Biopharma quarterly net profit margin?
The current quarterly net margin of CSCI is -307.59%
What is the all time high quarterly net margin for COSCIENS Biopharma?
COSCIENS Biopharma all-time high quarterly net profit margin is 71.45%
What is COSCIENS Biopharma quarterly net margin year-on-year change?
Over the past year, CSCI quarterly net profit margin has changed by -185.33% (-151.59%)